Angina pectoris, caused mainly due to decreased blood flow to the heart muscles, which induces chest pain or discomfort. The disorder typically occurs when enough oxygen is not obtained by the heart muscles. Angina pectoris is caused by the narrowing of the arteries that carry blood rich in oxygen to the heart. Coronary artery spasm, unstable plaques, reduced heart pumping function, and blood clots can also cause it. Common angina pectoris symptoms include chest pain or discomfort, shortness of breath, weakness, nausea and dizziness. Mild angina pectoris can be treated through lifestyle changes, such as quitting smoking, weight management, and a healthy diet. Medications such as beta-blockers, non-steroidal anti-inflammatory medications, ace inhibitors, calcium channel blockers, etc., are used to relieve the symptoms in the treatment of mild to extreme angina pectoris.
MARKET DYNAMICS
The high incidence rate of angina pectoris, recognition of therapeutic opportunities and increasing investments in research and development will spur the demand for Angina market. Additionally, easy availability of therapeutic drugs for angina pectoris, new product launches, and rise in awareness regarding various cardiological disorders will boost the market growth to significant extent over the forecast period. However, non-adherence to cardiovascular medications has been observed among patients with cardiovascular diseases buying of generic medicines instead of specific branded drugs hampers the growth of the market in the forecasted period.
MARKET SCOPE
The "Global Angina Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Angina market with detailed market segmentation by type, drug class, diagnosis, treatment, end-user and geography. The global Angina market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Angina market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global angina market is segmented on the type, drug class, diagnosis, treatment, and end-user. Based on type, the global angina market is segmented into stable angina and unstable angina, variant (prinzmetal) angina and microvascular angina, and others. Based on drug class, the global angina market is segmented into beta blockers, nitrates & calcium channel blockers, angiotensin-converting enzyme inhibitors, others. Based on diagnosis, the global angina market is segmented into imaging, blood test, stress test, and others. Based on treatment, the global angina market is segmented into lifestyle changes, medications, angioplasty and stenting, coronary bypass surgery, and others. Based on end user, the global angina market is segmented into hospitals, diagnostic centers, academic institutes, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Angina market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Angina market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Angina market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Angina market in these regions.
MARKET PLAYERS
The reports cover key developments in the Angina market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Angina market are anticipated to lucrative growth opportunities in the future with the rising demand for Angina market in the global market. Below mentioned is the list of few companies engaged in the Angina market.
The report also includes the profiles of key Angina market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Amgen Inc
- Pfizer Inc
- Johnson & Johnson Services, Inc.
- Novartis AG
- Bristol-Myers Squibb Company
- Abbott
- Bayer AG
- Orion Corporation
- Merck & Co. Inc.
- Cardiorentis AG
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.